AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 288: E685-E692, 2005. First published November 23, 2004; doi:10.1152/ajpendo.00444.2004
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/E685    most recent
00444.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toth, M. J.
Right arrow Articles by LeWinter, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toth, M. J.
Right arrow Articles by LeWinter, M. M.

Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity

Michael J. Toth, Dwight E. Matthews, Philp A. Ades, Marc D. Tischler, Peter Van Buren, Michael Previs, and Martin M. LeWinter

Department of Medicine, University of Vermont, Burlington, Vermont

Submitted 17 September 2004 ; accepted in final form 18 November 2004

Chronic heart failure is characterized by changes in skeletal muscle that contribute to physical disability. Most studies to date have investigated defects in skeletal muscle oxidative capacity. In contrast, less is known about how heart failure affects myofibrillar protein metabolism. Thus we examined the effect of heart failure on skeletal muscle myofibrillar protein metabolism, with a specific emphasis on changes in myosin heavy chain (MHC) protein content, synthesis, and isoform distribution in 10 patients with heart failure (63 ± 3 yr) and 11 controls (70 ± 3 yr). In addition, we examined the relationship of MHC protein metabolism to inflammatory markers and physical function. Although MHC and actin protein content did not differ between groups, MHC protein content decreased with increasing disease severity in heart failure patients (r = –0.748, P < 0.02), whereas actin protein content was not related to disease severity. No difference in MHC protein synthesis was found between groups, and MHC protein synthesis rates were not related to disease severity. There were, however, relationships between C-reactive protein and both MHC protein synthesis (r = –0.442, P = 0.05) and the ratio of MHC to mixed muscle protein synthesis (r = –0.493, P < 0.03). Heart failure patients showed reduced relative amounts of MHC I (P < 0.05) and a trend toward increased MHC IIx (P = 0.06). In regression analyses, decreased MHC protein content was related to decreased exercise capacity and muscle strength in heart failure patients. Our results demonstrate that heart failure affects both the quantity and isoform distribution of skeletal muscle MHC protein. The fact that MHC protein content was related to both exercise capacity and muscle strength further suggests that quantitative alterations in MHC protein may have functional significance.

sarcopenia; cardiac cachexia; myosin heavy chain isoform; cytokine; actin



Address for reprint requests and other correspondence: M. J. Toth, Health Science Research Facility 126 B, 149 Beaumont Ave., Univ. of Vermont, Burlington, VT 05405 (E-mail: michael.toth{at}uvm.edu)




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
Y. Okada, M. J. Toth, and P. VanBuren
Skeletal muscle contractile protein function is preserved in human heart failure
J Appl Physiol, April 1, 2008; 104(4): 952 - 957.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. M. W. Petersen, F. Magkos, P. Atherton, A. Selby, K. Smith, M. J. Rennie, B. K. Pedersen, and B. Mittendorfer
Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E843 - E848.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Liguzinski and B. Korzeniewski
Oxygen delivery by blood determines the maximal VO2 and work rate during whole body exercise in humans: in silico studies
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H343 - H353.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Toth, P. A. Ades, M. M. LeWinter, R. P. Tracy, and A. Tchernof
Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones
J Appl Physiol, January 1, 2006; 100(1): 35 - 41.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. Szentesi, M. A. Bekedam, B. J. van Beek-Harmsen, W. J. van der Laarse, R. Zaremba, A. Boonstra, F. C. Visser, and G. J. M. Stienen
Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure
J Appl Physiol, December 1, 2005; 99(6): 2189 - 2195.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.